BPC-157 is one of the most discussed research peptides, and also one surrounded by a lot of inaccurate information. This article gives an overview of the published research by research area, with links to in-depth articles in the Peptidera Knowledge Center.
First: almost all research is preclinical
The vast majority of the BPC-157 literature consists of cell and animal studies, mainly in rats. A 2026 systematic review found only three small human studies with thirty participants in total and very low certainty of evidence. Animal results are therefore not evidence of effects, safety or applicability in humans.
For scientific and informational purposes only; not medical advice. BPC-157 has no approved medical use. Peptidera products are intended exclusively for qualified laboratory research and not for human or animal consumption.
Research products for this article
COA reports for selected batches in our COA library